Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2048957

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2048957

Cell Isolation Market/Cell Separation Market by Product, Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

PUBLISHED:
PAGES: 525 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The cell isolation market is expected to reach USD 7.97 billion in 2031 from USD 4.39 billion in 2026, at a CAGR of 12.7% during the forecast period. The market is primarily driven by the expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, and increasing use of automated and closed isolation systems. Technologies such as centrifugation-based isolation, magnetic-activated cell separation, fluorescence-activated cell sorting, microfluidic isolation, and filtration-based separation enable the enrichment and purification of specific cell populations, including immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells. These technologies support applications across drug discovery, immunology research, cancer biology, regenerative medicine, biomarker discovery, and clinical research.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct, Cell Type, Cell Source, Technique, Application, and End User
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa

In addition, the growing demand for GMP-grade cell isolation products is driving adoption of validated kits, magnetic beads, single-use consumables, and closed-system platforms across clinical and manufacturing workflows. However, market growth continues to be challenged by the high cost of instruments and consumables, loss of cell viability and recovery during isolation, and difficulties in scaling research workflows to GMP manufacturing while balancing purity, yield, viability, and cost.

Cell Isolation Market - IMG1

"The consumables segment is expected to grow at the highest CAGR during the forecast period"

The consumables segment is projected to grow at the highest CAGR in the cell isolation market, driven by the recurring use of magnetic beads, antibody-based isolation kits, density gradient media, buffers, cell strainers, columns, and single-use kits across research and clinical workflows. These products are widely used for immune cell isolation, stem cell enrichment, isolation of circulating tumor cells, primary cell separation, and sample preparation for downstream analysis. The growing use of cell isolation in cell and gene therapy development, single-cell analysis, immunology research, and cancer biology is increasing demand for high-purity, validated, and application-specific consumables.

"Human cells segment holds the largest share of the market"

The human cells segment accounts for the largest share of the cell isolation market, driven by the increasing use of human-derived immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells in drug discovery, translational research, regenerative medicine, and clinical applications. Human cell isolation plays a critical role in immune profiling, biomarker discovery, cancer research, personalized medicine, and cell and gene therapy workflows. The growing demand for biologically relevant human cell models, along with the rising adoption of single-cell analysis and GMP-compatible cell processing, continues to strengthen this segment's position.

"The US is expected to grow at the highest CAGR during the forecast period"

The US is expected to grow at the highest CAGR in the cell isolation market due to its strong presence of leading life science companies, advanced biomedical research infrastructure, and high adoption of cell separation technologies across research and clinical settings. The rising use of cell isolation in cell and gene therapy development, immuno-oncology, stem cell research, single-cell analysis, and biomarker discovery is a key factor driving market growth. Technologies such as magnetic-activated cell separation, fluorescence-activated cell sorting, centrifugation-based isolation, and automated closed-system platforms are widely used across pharmaceutical companies, biotechnology firms, academic institutes, and clinical laboratories, further supporting demand.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side - 70% and Demand Side- 30%
  • By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe - 25%, Asia Pacific - 25%, Latin America - 5%, the Middle East & Africa - 5%

Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), Corning Incorporated (US), Lonza (Switzerland), Bio-Techne (US), Terumo Corporation (Japan), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), GenScript (US), Sony Group Corporation (Japan), Alfa Laval (Sweden), Promega Corporation (US), Cell Signaling Technology, Inc. (US), MiCareo Inc. (Taiwan), Applied Cells, Inc. (US), STEMCELL Technologies (Canada), Creative Bioarray (US), Proteintech Group, Inc. (US), MagBio Genomics, Inc. (US), Akadeum Life Sciences (US), pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG (Germany), and Invent Biotechnologies, Inc. (US) are some of the key companies offering cell isolation products.

Research Coverage

This research report categorizes the cell isolation market by product (consumables [reagents & kits {cell isolation reagents & kits, tissue dissociation reagents & kits, other reagents & kits}, media and sera, beads {magnetic beads, fluorescent beads}, and disposables] and instruments [centrifuges, cell sorters, magnetic-activated cell separator systems, filtration systems, and other instruments]), cell type (human cells [differentiated cells, stem cells] and animal cells), cell source (blood & blood-derived samples, adipose tissue, bone marrow, cord blood/embryonic stem cells, and other cell sources), technique (centrifugation-based cell isolation, surface marker-based cell isolation, filtration-based cell isolation, and microfluidics & label-free cell isolation), application (research applications [biomolecule isolation, cancer research, stem cell research, regenerative medicine, and other research applications], drug discovery and development, in vitro diagnostics, CGT manufacturing), end user (pharmaceutical & biotechnology companies, academic & research institutes, biopharmaceutical companies, hospitals & diagnostic laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

The report's scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the cell isolation market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, key strategies, new product launches, acquisitions, and recent developments in the cell isolation market. This report also includes a competitive analysis of emerging startups in the cell isolation industry ecosystem.

Key Benefits of Buying the Report

The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, shift toward automated and closed isolation systems), restraints (high cost of instruments and consumables, loss of cell viability and recovery during isolation), opportunities (growing demand for GMP-grade cell isolation products, adoption of microfluidic and label-free isolation technologies), and challenges (scaling research workflows to GMP manufacturing, balancing purity, yield, viability, and cost) influencing the market growth
  • Product Development/Innovation: Detailed insights into newly launched products and innovations in the cell isolation market
  • Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players, Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US), among others, for the cell isolation market
Show more
Product Code: BT 2435

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN CELL ISOLATION MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 CELL ISOLATION MARKET OVERVIEW
  • 3.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY
  • 3.3 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.4 CELL ISOLATION MARKET SHARE, BY PRODUCT, 2026 VS. 2031 (%)

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Expansion of cell and gene therapy workflows
      • 4.2.1.2 Rising demand for immune cell isolation
      • 4.2.1.3 Growing adoption of single-cell analysis
      • 4.2.1.4 Shift toward automated and closed isolation systems
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High cost of instruments and consumables
      • 4.2.2.2 Loss of cell viability and recovery during isolation
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing demand for GMP-grade cell isolation products
      • 4.2.3.2 Adoption of microfluidic and label-free isolation technologies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Scaling research workflows to GMP manufacturing
      • 4.2.4.2 Balancing purity, yield, viability, and cost
  • 4.3 UNMET NEEDS & WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
    • 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023-2025
    • 5.5.2 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023-2025
    • 5.5.3 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023-2025
    • 5.5.4 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023-2025
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT SCENARIO (HS CODE 3822.00)
    • 5.6.2 EXPORT SCENARIO (HS CODE 3822.00)
  • 5.7 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 INVESTMENT & FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 MICROFLUIDIC CELL SORTING IMPROVES CAR-T STARTING MATERIAL QUALITY
    • 5.10.2 CLOSED-SYSTEM CELL ENRICHMENT SUPPORTS NK CELL MANUFACTURING
    • 5.10.3 MICROFLUIDIC ISOLATION ENHANCES CTC RECOVERY IN PANCREATIC CANCER
  • 5.11 IMPACT OF 2025 US TARIFFS ON CELL ISOLATION MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRY/REGION
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON END-USE INDUSTRIES
      • 5.11.5.1 Pharmaceutical & biotechnology companies
      • 5.11.5.2 Academic & research institutes
      • 5.11.5.3 Hospitals & diagnostic laboratories

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Centrifugation-based techniques
      • 6.1.1.2 Magnetic cell isolation
      • 6.1.1.3 Fluorescence-activated cell sorting
      • 6.1.1.4 Acoustofluidic cell isolation
      • 6.1.1.5 Filtration & size-based cell isolation
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Mass cytometry
      • 6.1.2.2 Cell imaging technologies
      • 6.1.2.3 AI-enabled image-based sorting
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Single-cell sequencing
      • 6.1.3.2 CRISPR & gene editing
      • 6.1.3.3 3D cell culture & organoids
  • 6.2 TECHNOLOGY ROADMAP
  • 6.3 PATENT ANALYSIS
    • 6.3.1 METHODOLOGY
    • 6.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
    • 6.3.3 LIST OF KEY PATENTS
  • 6.4 FUTURE APPLICATIONS
  • 6.5 IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET
    • 6.5.1 TOP USE CASES & MARKET POTENTIAL
    • 6.5.2 BEST PRACTICES IN AI-ENABLED CELL ISOLATION WORKFLOWS
    • 6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET
    • 6.5.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
    • 6.5.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 7.1 DECISION-MAKING PROCESS
  • 7.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
    • 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 7.2.2 KEY BUYING CRITERIA, BY END USER
  • 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 7.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8 SUSTAINABILITY & REGULATORY LANDSCAPE

  • 8.1 REGIONAL REGULATIONS & COMPLIANCE
    • 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 8.1.2 INDUSTRY STANDARDS
      • 8.1.2.1 North America
      • 8.1.2.2 Europe
      • 8.1.2.3 Asia Pacific
      • 8.1.2.4 Rest of the world
  • 8.2 SUSTAINABILITY INITIATIVES
  • 8.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
  • 8.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

9 CELL ISOLATION MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 CONSUMABLES
    • 9.2.1 REAGENTS & KITS
      • 9.2.1.1 Cell isolation reagents & kits
        • 9.2.1.1.1 Expansion of downstream single-cell genomics to drive market
      • 9.2.1.2 Tissue dissociation reagents & kits
        • 9.2.1.2.1 Influx of solid tumor oncology profiling and primary cell culture derivations to drive growth
      • 9.2.1.3 Other reagents & kits
    • 9.2.2 MEDIA & SERA
      • 9.2.2.1 Rising focus on viable, reproducible, and clinically compatible isolated cell workflows to fuel market
    • 9.2.3 BEADS
      • 9.2.3.1 Growing demand for beads in T-cell and stem cell isolation to drive market growth
    • 9.2.4 DISPOSABLES
      • 9.2.4.1 Growing government investments in research to aid market growth
  • 9.3 INSTRUMENTS
    • 9.3.1 CENTRIFUGES
      • 9.3.1.1 Growing use in pharma-biotech industry to boost market
    • 9.3.2 CELL SORTERS
      • 9.3.2.1 Rise in cell-based research initiatives to augment growth
    • 9.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
      • 9.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market
    • 9.3.4 FILTRATION SYSTEMS
      • 9.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market
    • 9.3.5 OTHER INSTRUMENTS

10 CELL ISOLATION MARKET, BY CELL TYPE

  • 10.1 INTRODUCTION
  • 10.2 HUMAN CELLS
    • 10.2.1 DIFFERENTIATED CELLS
      • 10.2.1.1 Rising use of mature human cell populations in translational research and drug development to fuel growth
    • 10.2.2 STEM CELLS
      • 10.2.2.1 Rise in grants and funding for stem cell research to drive market
  • 10.3 ANIMAL CELLS
    • 10.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH

11 CELL ISOLATION MARKET, BY CELL SOURCE

  • 11.1 INTRODUCTION
  • 11.2 BLOOD & BLOOD-DERIVED SAMPLES
    • 11.2.1 GROWING USE OF IMMUNE CELL ISOLATION FROM BLOOD-DERIVED SAMPLES TO DRIVE MARKET
  • 11.3 ADIPOSE TISSUE
    • 11.3.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET
  • 11.4 BONE MARROW
    • 11.4.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH
  • 11.5 CORD BLOOD/EMBRYONIC STEM CELLS
    • 11.5.1 GROWING USE OF STEM AND PROGENITOR CELL ISOLATION IN REGENERATIVE MEDICINE AND CELL THERAPY RESEARCH TO SUPPORT MARKET GROWTH
  • 11.6 OTHER CELL SOURCES

12 CELL ISOLATION MARKET, BY TECHNIQUE

  • 12.1 INTRODUCTION
  • 12.2 CENTRIFUGATION-BASED CELL ISOLATION
    • 12.2.1 RISING DEMAND FOR SCALABLE, AUTOMATED, AND CLOSED CELL PREPARATION WORKFLOWS TO FUEL MARKET
  • 12.3 SURFACE MARKER-BASED CELL ISOLATION
    • 12.3.1 GROWING NEED FOR MARKER-SPECIFIC AND HIGH-PURITY CELL POPULATIONS TO PROPEL MARKET
  • 12.4 FILTRATION-BASED CELL ISOLATION
    • 12.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET
  • 12.5 MICROFLUIDICS & LABEL-FREE CELL ISOLATION
    • 12.5.1 HIGH DEMAND FOR ONCOLOGY RESEARCH TO SUPPORT SEGMENTAL GROWTH

13 CELL ISOLATION MARKET, BY APPLICATION

  • 13.1 INTRODUCTION
  • 13.2 RESEARCH APPLICATIONS
    • 13.2.1 BIOMOLECULE ISOLATION
      • 13.2.1.1 Increasing demand for biopharmaceutical products to fuel market
    • 13.2.2 CANCER RESEARCH
      • 13.2.2.1 Precision oncology and rare tumor cell analysis to drive market
    • 13.2.3 STEM CELL RESEARCH
      • 13.2.3.1 Rising grants and funding for stem cell research to augment growth
    • 13.2.4 REGENERATIVE MEDICINE
      • 13.2.4.1 Expanding stem cell and translational therapy research to support market
    • 13.2.5 OTHER RESEARCH APPLICATIONS
  • 13.3 DRUG DISCOVERY & DEVELOPMENT
    • 13.3.1 RISING ADOPTION OF CELL-BASED DRUG DISCOVERY AND PRECISION THERAPEUTICS TO PROPEL MARKET
  • 13.4 IN VITRO DIAGNOSTICS
    • 13.4.1 RISING ADOPTION OF LIQUID BIOPSY AND PRECISION DIAGNOSTICS TO PROPEL MARKET
  • 13.5 CGT MANUFACTURING
    • 13.5.1 EXPANSION OF GMP-COMPLIANT CGT MANUFACTURING CAPACITY TO PROPEL MARKET

14 CELL ISOLATION MARKET, BY END USER

  • 14.1 INTRODUCTION
  • 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 14.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH
  • 14.3 ACADEMIC & RESEARCH INSTITUTES
    • 14.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT
  • 14.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 14.4.1 RISING DEMAND FOR ENRICHED CLINICAL CELL POPULATIONS IN ONCOLOGY AND HEMATOLOGY DIAGNOSTICS TO DRIVE MARKET
  • 14.5 OTHER END USERS

15 CELL ISOLATION MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 US
      • 15.2.1.1 Strong biopharma R&D and advanced cell sorting adoption to drive market
    • 15.2.2 CANADA
      • 15.2.2.1 Expanding cell therapy manufacturing and regenerative medicine research to propel market
  • 15.3 EUROPE
    • 15.3.1 GERMANY
      • 15.3.1.1 Strong cell & gene therapy translation and GMP-ready automated cell processing to aid market growth
    • 15.3.2 UK
      • 15.3.2.1 Expanding advanced therapy infrastructure and GMP-compatible cell processing workflows to drive market
    • 15.3.3 FRANCE
      • 15.3.3.1 Expanding biotherapy research and cell & gene therapy infrastructure to drive market
    • 15.3.4 ITALY
      • 15.3.4.1 Expanding advanced therapy trials and ex vivo gene therapy capabilities to drive market
    • 15.3.5 SPAIN
      • 15.3.5.1 Hospital-based CAR-T manufacturing and GMP-compatible cell processing workflows to aid growth
    • 15.3.6 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 CHINA
      • 15.4.1.1 Expanding cell therapy pipelines and regenerative medicine commercialization to boost market
    • 15.4.2 JAPAN
      • 15.4.2.1 iPSC research leadership, regenerative medicine commercialization, and domestic cell therapy manufacturing expansion to drive market growth
    • 15.4.3 INDIA
      • 15.4.3.1 BioE3-led biomanufacturing and translational research expansion propel market
    • 15.4.4 AUSTRALIA
      • 15.4.4.1 Hospital-linked GMP cell therapy capacity, regenerative medicine trials, and translational research infrastructure to fuel market
    • 15.4.5 SOUTH KOREA
      • 15.4.5.1 Bioprocessing infrastructure expansion and regenerative medicine focus to support market growth
    • 15.4.6 REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    • 15.5.1 BRAZIL
      • 15.5.1.1 Advanced therapy regulation and oncology research strength to drive market
    • 15.5.2 MEXICO
      • 15.5.2.1 Regulatory strengthening and pharmaceutical infrastructure growth to support the market
    • 15.5.3 REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST
    • 15.6.1 GCC COUNTRIES
      • 15.6.1.1 Saudi Arabia
        • 15.6.1.1.1 Local advanced therapy manufacturing and precision medicine investment to boost market
      • 15.6.1.2 UAE
        • 15.6.1.2.1 Stem cell research infrastructure and regenerative medicine standards to aid market growth
      • 15.6.1.3 Rest of GCC Countries
    • 15.6.2 REST OF MIDDLE EAST
  • 15.7 AFRICA
    • 15.7.1 POPULATION-SPECIFIC ONCOLOGY RESEARCH AND INFECTIOUS DISEASE STUDIES TO PROPEL MARKET

16 COMPETITIVE LANDSCAPE

  • 16.1 OVERVIEW
  • 16.2 KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2023-APRIL 2026
    • 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023-APRIL 2026
  • 16.3 REVENUE ANALYSIS, 2021-2025
  • 16.4 MARKET SHARE ANALYSIS, 2025
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Region footprint
      • 16.5.5.3 Product footprint
      • 16.5.5.4 Cell type footprint
      • 16.5.5.5 End-user footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 RESPONSIVE COMPANIES
    • 16.6.3 DYNAMIC COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 16.6.5.1 Detailed list of key startup/SME players
      • 16.6.5.2 Competitive benchmarking of startups/SMEs
  • 16.7 COMPANY VALUATION & FINANCIAL METRICS
    • 16.7.1 COMPANY VALUATION
    • 16.7.2 FINANCIAL METRICS
  • 16.8 BRAND/PRODUCT COMPARISON
  • 16.9 COMPETITIVE SCENARIO
    • 16.9.1 PRODUCT LAUNCHES
    • 16.9.2 DEALS
    • 16.9.3 EXPANSIONS

17 COMPANY PROFILES

  • 17.1 KEY PLAYERS
    • 17.1.1 DANAHER CORPORATION
      • 17.1.1.1 Business overview
      • 17.1.1.2 Products offered
      • 17.1.1.3 Recent developments
        • 17.1.1.3.1 Deals
      • 17.1.1.4 MnM view
        • 17.1.1.4.1 Key strengths
        • 17.1.1.4.2 Strategic choices
        • 17.1.1.4.3 Weaknesses & competitive threats
    • 17.1.2 MERCK KGAA
      • 17.1.2.1 Business overview
      • 17.1.2.2 Products offered
      • 17.1.2.3 Recent developments
        • 17.1.2.3.1 Deals
        • 17.1.2.3.2 Expansions
      • 17.1.2.4 MnM view
        • 17.1.2.4.1 Key strengths
        • 17.1.2.4.2 Strategic choices
        • 17.1.2.4.3 Weaknesses & competitive threats
    • 17.1.3 THERMO FISHER SCIENTIFIC INC.
      • 17.1.3.1 Business overview
      • 17.1.3.2 Products offered
      • 17.1.3.3 Recent developments
        • 17.1.3.3.1 Product launches
        • 17.1.3.3.2 Deals
        • 17.1.3.3.3 Expansions
      • 17.1.3.4 MnM view
        • 17.1.3.4.1 Key strengths
        • 17.1.3.4.2 Strategic choices
        • 17.1.3.4.3 Weaknesses & competitive threats
    • 17.1.4 BECTON, DICKINSON AND COMPANY
      • 17.1.4.1 Business overview
      • 17.1.4.2 Products offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Product launches
        • 17.1.4.3.2 Deals
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Key strengths
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses & competitive threats
    • 17.1.5 AGILENT TECHNOLOGIES, INC.
      • 17.1.5.1 Business overview
      • 17.1.5.2 Products offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Deals
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Key strengths
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses & competitive threats
    • 17.1.6 SARTORIUS AG
      • 17.1.6.1 Business overview
      • 17.1.6.2 Products offered
    • 17.1.7 BIO-RAD LABORATORIES, INC.
      • 17.1.7.1 Business overview
      • 17.1.7.2 Products offered
      • 17.1.7.3 Recent developments
        • 17.1.7.3.1 Product launches
    • 17.1.8 QIAGEN
      • 17.1.8.1 Business overview
      • 17.1.8.2 Products offered
      • 17.1.8.3 Recent developments
        • 17.1.8.3.1 Deals
    • 17.1.9 F. HOFFMANN-LA ROCHE LTD.
      • 17.1.9.1 Business overview
      • 17.1.9.2 Products offered
      • 17.1.9.3 Recent developments
        • 17.1.9.3.1 Expansions
    • 17.1.10 REVVITY
      • 17.1.10.1 Business overview
      • 17.1.10.2 Products offered
    • 17.1.11 CORNING INCORPORATED
      • 17.1.11.1 Business overview
      • 17.1.11.2 Products offered
    • 17.1.12 LONZA
      • 17.1.12.1 Business overview
      • 17.1.12.2 Products offered
    • 17.1.13 BIO-TECHNE
      • 17.1.13.1 Business overview
      • 17.1.13.2 Products offered
    • 17.1.14 TERUMO CORPORATION
      • 17.1.14.1 Business overview
      • 17.1.14.2 Products offered
    • 17.1.15 MILTENYI BIOTEC
      • 17.1.15.1 Business overview
      • 17.1.15.2 Products offered
    • 17.1.16 TAKARA BIO INC.
      • 17.1.16.1 Business overview
      • 17.1.16.2 Products offered
    • 17.1.17 GENSCRIPT
      • 17.1.17.1 Business overview
      • 17.1.17.2 Products offered
      • 17.1.17.3 Recent developments
        • 17.1.17.3.1 Deals
    • 17.1.18 SONY CORPORATION
      • 17.1.18.1 Business overview
      • 17.1.18.2 Products offered
    • 17.1.19 ALFA LAVAL
      • 17.1.19.1 Business overview
      • 17.1.19.2 Products offered
      • 17.1.19.3 Recent developments
        • 17.1.19.3.1 Product launches
        • 17.1.19.3.2 Deals
  • 17.2 OTHER PLAYERS
    • 17.2.1 PROMEGA CORPORATION
    • 17.2.2 CELL SIGNALING TECHNOLOGY, INC.
    • 17.2.3 MICAREO INC.
    • 17.2.4 APPLIED CELLS, INC.
    • 17.2.5 STEMCELL TECHNOLOGIES
    • 17.2.6 CREATIVE BIOARRAY
    • 17.2.7 PROTEINTECH GROUP, INC.
    • 17.2.8 MAGBIO GENOMICS, INC.
    • 17.2.9 AKADEUM LIFE SCIENCES
    • 17.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
    • 17.2.11 INVENT BIOTECHNOLOGIES, INC.

18 RESEARCH METHODOLOGY

  • 18.1 RESEARCH DATA
    • 18.1.1 SECONDARY DATA
      • 18.1.1.1 Key data from secondary sources
    • 18.1.2 PRIMARY DATA
      • 18.1.2.1 Key data from primary sources
      • 18.1.2.2 Key primary participants
      • 18.1.2.3 Breakdown of primary interviews
      • 18.1.2.4 Key industry insights
  • 18.2 MARKET SIZE ESTIMATION
    • 18.2.1 GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025
    • 18.2.2 SEGMENTAL MARKET SIZE ESTIMATION
  • 18.3 MARKET GROWTH RATE PROJECTIONS
  • 18.4 DATA TRIANGULATION
  • 18.5 FACTOR ANALYSIS
  • 18.6 RESEARCH ASSUMPTIONS
  • 18.7 RESEARCH LIMITATIONS & RISK ASSESSMENT

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS
Show more
Product Code: BT 2435

List of Tables

  • TABLE 1 CELL ISOLATION MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 3 CELL ISOLATION MARKET: PORTER'S FIVE FORCES
  • TABLE 4 CELL ISOLATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 5 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023-2025 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023-2025 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023-2025 (USD)
  • TABLE 8 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023-2025 (USD)
  • TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 11 CELL ISOLATION MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027
  • TABLE 12 RECIPROCAL TARIFF RATES ADJUSTED BY US
  • TABLE 13 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
  • TABLE 14 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025
  • TABLE 15 LIST OF KEY PATENTS IN CELL ISOLATION MARKET, 2023-2025
  • TABLE 16 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET
  • TABLE 17 CLIENTS' READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES IN CELL ISOLATION MARKET
  • TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • TABLE 19 KEY BUYING CRITERIA, BY END USER
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 25 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 26 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 27 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 29 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 31 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 32 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 33 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 34 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 39 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 40 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 41 CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 NORTH AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 EUROPE: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 LATIN AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 MIDDLE EAST: CELL ISOLATION REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 GCC COUNTRIES: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 49 NORTH AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 EUROPE: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 LATIN AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 MIDDLE EAST: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 GCC COUNTRIES: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 OTHER REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 56 NORTH AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 EUROPE: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 LATIN AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 MIDDLE EAST: OTHER REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 GCC COUNTRIES: OTHER REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 64 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 68 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 70 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 75 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 77 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 82 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 88 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 91 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 92 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 93 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 95 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 97 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 99 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 102 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 103 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 104 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 106 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 109 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 110 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 111 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 113 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 116 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 118 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 119 OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 120 NORTH AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 EUROPE: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 123 LATIN AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 124 MIDDLE EAST: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 125 GCC COUNTRIES: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 128 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 131 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 133 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 134 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 135 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 136 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 140 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 141 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 142 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 143 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 147 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 148 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 150 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 153 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 154 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 157 CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 158 NORTH AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 159 EUROPE: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 161 LATIN AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 162 MIDDLE EAST: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 163 GCC COUNTRIES: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 166 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 169 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 170 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 172 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 173 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 175 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 176 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 177 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 179 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 180 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 182 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 183 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 184 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 186 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 187 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 190 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 191 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 192 CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 193 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 194 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 195 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 197 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 198 MIDDLE EAST: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 199 GCC COUNTRIES: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 200 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 201 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 202 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 204 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 205 MIDDLE EAST: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 207 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 208 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 209 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 211 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 212 MIDDLE EAST: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 215 NORTH AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 216 EUROPE: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 218 LATIN AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 219 MIDDLE EAST: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 221 CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 222 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 223 NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 224 EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 226 LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 227 MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 229 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 231 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 232 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 234 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 235 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 237 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 238 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 239 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 241 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 242 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 244 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 245 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 246 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 248 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 249 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 251 CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 252 NORTH AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 253 EUROPE: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 255 LATIN AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 256 MIDDLE EAST: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 258 CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 259 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 260 EUROPE: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 262 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 263 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 265 CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 267 EUROPE: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 268 ASIA PACIFIC: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 269 LATIN AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 270 MIDDLE EAST: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 271 GCC COUNTRIES: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 272 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 273 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 274 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 276 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 277 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 279 CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 280 NORTH AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 281 EUROPE: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 283 LATIN AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 284 MIDDLE EAST: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 286 CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 287 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 288 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 289 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 291 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 292 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 293 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 294 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 295 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 296 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 298 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 299 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 300 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 301 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 302 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 303 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 305 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 306 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 307 GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 308 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 309 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 310 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 312 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 313 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 314 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 315 CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 316 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 317 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 318 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 323 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 324 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 325 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 326 NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 327 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 328 US: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 329 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 US: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 332 US: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 334 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 335 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 336 US: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 337 US: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 US: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 339 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 340 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 342 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 343 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 344 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 345 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 346 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 347 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 348 CANADA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 CANADA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 350 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 351 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 352 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 353 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 355 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 358 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 359 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 360 EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 EUROPE: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 362 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 363 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 364 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 365 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 367 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 369 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 370 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 371 GERMANY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 GERMANY: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 373 UK: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 374 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 375 UK: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 377 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 380 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 381 UK: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 382 UK: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 UK: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 384 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 385 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 386 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 387 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 391 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 392 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 393 FRANCE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 394 FRANCE: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 395 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 396 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 397 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 400 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 401 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 402 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 403 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 404 ITALY: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 405 ITALY: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 406 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 407 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 412 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 413 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 414 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 415 SPAIN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 416 SPAIN: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 417 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 418 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 421 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 422 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 423 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 424 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 425 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 426 REST OF EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 428 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 429 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 430 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 431 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 432 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 433 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 435 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 436 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 437 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 438 ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 439 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 440 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 441 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 442 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 443 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 444 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 445 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 446 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 447 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 448 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 449 CHINA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 450 CHINA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 451 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 452 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 453 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 454 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 455 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 456 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 457 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 458 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 459 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 460 JAPAN: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 461 JAPAN: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 462 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 463 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 464 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 465 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 466 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 467 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 468 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 469 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 470 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 471 INDIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 472 INDIA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 473 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 474 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 475 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 476 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 477 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 478 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 479 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 480 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 481 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 482 AUSTRALIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 483 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 484 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 485 SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 486 SOUTH KOREA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 487 SOUTH KOREA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 488 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 489 SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 490 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 491 SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 492 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 493 SOUTH KOREA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 494 SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 495 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 496 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 497 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 498 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 499 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 500 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 501 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 502 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 503 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 504 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 505 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 506 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 507 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 508 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 509 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 510 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 511 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 512 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 513 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 514 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 515 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 516 LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 517 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 518 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 519 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 520 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 521 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 522 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 523 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 524 BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 525 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 526 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 527 BRAZIL: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 528 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 529 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 530 MEXICO: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 531 MEXICO: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 532 MEXICO: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 533 MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 534 MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 535 MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 536 MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 537 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 538 MEXICO: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 539 MEXICO: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 540 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 541 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 542 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 543 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 544 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 545 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 546 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 547 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 548 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 549 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 550 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)

List of Figures

  • TABLE 551 MIDDLE EAST: CELL ISOLATION MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 552 MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 553 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 554 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 555 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 556 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 557 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 558 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 559 MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 560 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 561 MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 562 MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 563 GCC COUNTRIES: CELL ISOLATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 564 GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 565 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 566 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 567 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 568 GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 569 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 570 GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 571 GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 572 GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 573 GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 574 GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 575 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 576 SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 577 SAUDI ARABIA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 578 SAUDI ARABIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 579 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 580 SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 581 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 582 SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 583 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 584 SAUDI ARABIA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 585 SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 586 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 587 UAE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 588 UAE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 589 UAE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 590 UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 591 UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 592 UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 593 UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 594 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 595 UAE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 596 UAE: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 597 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 598 REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 599 REST OF GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 600 REST OF GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 601 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 602 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 603 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 604 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 605 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 606 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 607 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 608 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 609 REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 610 REST OF MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 611 REST OF MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 612 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 613 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 614 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 615 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 616 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 617 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 618 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 619 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 620 AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 621 AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 622 AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 623 AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
  • TABLE 624 AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 625 AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2024-2031 (USD MILLION)
  • TABLE 626 AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
  • TABLE 627 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 628 AFRICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 629 AFRICA: CELL ISOLATION MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 630 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023-APRIL 2026
  • TABLE 631 CELL ISOLATION MARKET: DEGREE OF COMPETITION
  • TABLE 632 CELL ISOLATION MARKET: REGION FOOTPRINT
  • TABLE 633 CELL ISOLATION MARKET: PRODUCT FOOTPRINT
  • TABLE 634 CELL ISOLATION MARKET: CELL TYPE FOOTPRINT
  • TABLE 635 CELL ISOLATION MARKET: END-USER FOOTPRINT
  • TABLE 636 CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 637 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 638 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 639 CELL ISOLATION MARKET: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 640 CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2023-APRIL 2026
  • TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 642 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 644 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 645 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 646 MERCK KGAA: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 647 MERCK KGAA: EXPANSIONS, JANUARY 2023-APRIL 2026
  • TABLE 648 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 649 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 650 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 651 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 652 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
  • TABLE 653 BD: COMPANY OVERVIEW
  • TABLE 654 BD: PRODUCTS OFFERED
  • TABLE 655 BD: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 656 BD: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 657 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 658 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 659 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 660 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 661 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 662 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 663 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 664 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 665 QIAGEN: COMPANY OVERVIEW
  • TABLE 666 QIAGEN: PRODUCTS OFFERED
  • TABLE 667 QIAGEN: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 668 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 669 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 670 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2023-APRIL 2026
  • TABLE 671 REVVITY: COMPANY OVERVIEW
  • TABLE 672 REVVITY: PRODUCTS OFFERED
  • TABLE 673 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 674 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 675 LONZA: COMPANY OVERVIEW
  • TABLE 676 LONZA: PRODUCTS OFFERED
  • TABLE 677 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 678 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 679 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 680 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 681 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 682 MILTENYI BIOTEC: PRODUCTS OFFERED
  • TABLE 683 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 684 TAKARA BIO INC.: PRODUCTS OFFERED
  • TABLE 685 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 686 GENSCRIPT: PRODUCTS OFFERED
  • TABLE 687 GENSCRIPT: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 688 SONY CORPORATION: COMPANY OVERVIEW
  • TABLE 689 SONY CORPORATION: PRODUCTS OFFERED
  • TABLE 690 ALFA LAVAL: COMPANY OVERVIEW
  • TABLE 691 ALFA LAVAL: PRODUCTS OFFERED
  • TABLE 692 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
  • TABLE 693 ALFA LAVAL: DEALS, JANUARY 2023-APRIL 2026
  • TABLE 694 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 695 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 696 MICAREO INC.: COMPANY OVERVIEW
  • TABLE 697 APPLIED CELLS, INC.: COMPANY OVERVIEW
  • TABLE 698 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 699 CREATIVE BIOARRAY: COMPANY OVERVIEW
  • TABLE 700 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
  • TABLE 701 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW
  • TABLE 702 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
  • TABLE 703 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG: COMPANY OVERVIEW
  • TABLE 704 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 705 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 706 RISK ASSESSMENT

List of Figures

  • FIGURE 1 CELL ISOLATION MARKET SEGMENTATION & REGIONS CONSIDERED
  • FIGURE 2 CELL ISOLATION MARKET: YEARS CONSIDERED
  • FIGURE 3 MARKET SCENARIO
  • FIGURE 4 GLOBAL CELL ISOLATION MARKET, 2024-2031
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, 2023-2026
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF CELL ISOLATION MARKET
  • FIGURE 7 HIGH-GROWTH SEGMENTS IN CELL ISOLATION MARKET, 2026-2031
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN CELL ISOLATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 9 RISING ADOPTION OF STEM CELL RESEARCH AND IMMUNOLOGY RESEARCH TO DRIVE MARKET GROWTH
  • FIGURE 10 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF CELL ISOLATION MARKET IN NORTH AMERICA IN 2025
  • FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL CELL ISOLATION MARKET DURING FORECAST PERIOD
  • FIGURE 12 CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 13 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 CELL ISOLATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 16 CELL ISOLATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 17 AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
  • FIGURE 18 AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY KEY PLAYER, 2025 (USD)
  • FIGURE 19 AVERAGE SELLING PRICE OF CELL ISOLATION INSTRUMENTS, BY REGION, 2025 (USD)
  • FIGURE 20 AVERAGE SELLING PRICE OF CELL ISOLATION CONSUMABLES, BY REGION, 2025 (USD)
  • FIGURE 21 CELL ISOLATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 22 INVESTMENT & FUNDING SCENARIO, 2023-2025 (USD MILLION)
  • FIGURE 23 PATENT APPLICATIONS IN CELL ISOLATION MARKET, JANUARY 2015-DECEMBER 2025
  • FIGURE 24 IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 26 KEY BUYING CRITERIA, BY END USER
  • FIGURE 27 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2021-2025 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL ISOLATION MARKET, 2025
  • FIGURE 31 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 32 CELL ISOLATION MARKET: COMPANY FOOTPRINT
  • FIGURE 33 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 35 EV/EBITDA OF KEY VENDORS
  • FIGURE 36 CELL ISOLATION MARKET: BRAND COMPARISON
  • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 40 BD: COMPANY SNAPSHOT (2025)
  • FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2025)
  • FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 QIAGEN: COMPANY SNAPSHOT (2025)
  • FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 46 REVVITY: COMPANY SNAPSHOT (2025)
  • FIGURE 47 CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
  • FIGURE 48 LONZA: COMPANY SNAPSHOT (2025)
  • FIGURE 49 BIO-TECHNE: COMPANY SNAPSHOT (2025)
  • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 GENSCRIPT: COMPANY SNAPSHOT (2025)
  • FIGURE 53 SONY CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 ALFA LAVAL: COMPANY SNAPSHOT (2025)
  • FIGURE 55 CELL ISOLATION MARKET: RESEARCH DESIGN
  • FIGURE 56 CELL ISOLATION MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 57 CELL ISOLATION MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 58 GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025
  • FIGURE 59 CELL ISOLATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
  • FIGURE 60 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025)
  • FIGURE 61 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 62 CELL ISOLATION MARKET: CAGR PROJECTIONS
  • FIGURE 63 CELL ISOLATION MARKET: DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!